Specifically, a major contribution of our work is the proposal of RAGE-JAK2-STAT3 as a novel therapeutic target that would influence the mitochondrial dynamics and restore normal mitochondrial function and prevent vascular complications in diabetes. This evidence concerns the gene AGER and diabetes mellitus.